IP Library Granted Patent US 8,133,191
Granted Patent B2
US 8,133,191 · App. 11/355,181 · Granted Mar 13, 2012

Method and apparatus for treatment of adipose tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,133,191
App. No.
11/355,181
Granted
Mar 13, 2012
Kind
B2
Abstract

The invention provides methods and apparatuses for the treatment of adipose tissue. The methods comprise application of ultrasound energy to a region of adipose tissue, and the apparatuses comprise at least one source of ultrasound energy configured to direct ultrasound energy through a skin surface into the subcutaneous adipose tissue. In one embodiment, a pressure gradient is created in the region generating relative movement between fat cell constituents having different densities. In another embodiment, a protrusion of skin and underlying adipose tissue containing is formed and ultrasound energy is radiated into the adipose tissue in the protrusion. In another embodiment, an RF electric field is generated inside a region of adipose tissue together with the ultrasound energy.

Claims (43)

1. A method for selective destruction of adipocytes in adipose tissue, the method comprising:

(a) applying at least one source of moderately focused ultrasound energy limited to a view angle of less than 120° to a skin surface to generate a pressure gradient between 0.5 GPa/m to 50 GPa/m in the adipose tissue;

(b) enhancing the pressure gradient at an expense of pressure amplitude at the focus volume by limiting the focusing of the ultrasound energy, such that selective effects on adipocytes will be obtained with reduced cavitation; and

(c) generating relative movement between lipids and other constituents of adipocytes with sufficient intensity to rupture cell membranes of the adipocytes.

2. The method according to claim 1 , wherein the constituents of adipocytes comprise one or more of a lipid vacuole, cytoplasm fluid and intercellular fluids having different mass densities.

3. The method according to claim 1 , wherein the moderately focused ultrasound energy is limited to a view angle of less than 90°, said angle is limited to maximize a ratio of the pressure gradient to a pressure at the focus volume.

4. The method according to claim 1 , wherein to avoid penetration of the ultrasound energy to internal tissues and organs below an adipose tissue layer, the moderately focused ultrasound energy is radiated into a protrusion formed of the skin surface including the adipose tissue in a direction creating an angle of 90 degrees with a normal to the non-protruding skin surface.

5. The method according to claim 4 , wherein the protrusion is formed by one of vacuum means or mechanical manipulation of the adipose tissue.

6. The method according to claim 5 , wherein the protrusion is formed by the mechanical manipulation of the adipose tissue.

7. The method according to claim 5 , wherein the protrusion is formed by the vacuum means.

8. The method according to claim 4 , wherein the ultrasound energy radiated by the source is transmitted through the protruding tissue region.

9. The method according to claim 1 , wherein the moderately focused ultrasound energy has a frequency lower than 1 MHz.

10. The method according to claim 1 , wherein differences between mass density of the constituents of the adipocytes assist in generating the relative movement between them.

11. The method according to claim 1 , further comprising reducing unwanted cavitation effects while not reducing cell rupturing by moderately focusing the ultrasound energy and controlling a negative pressure magnitude of the ultrasound such that a pressure level does not cause the cavitation in the adipocytes constituents.

12. The method according to claim 11 , further comprising detecting a generation of the cavitation in the adipose tissue by a sensor comprising a receiver tuned to half of an ultrasound transmitting frequency and varying ultrasound properties by a control unit to minimize unwanted effects of the cavitation.

13. The method according to claim 1 , wherein the moderately focused ultrasound energy generates the pressure gradient, more preferred between 2 GPa/m to 15 GPa/m.

14. The method according to claim 13 , wherein the moderately focused ultrasound energy has a frequency lower than 1 MHz.

15. A method for enhancing selective destruction of adipocytes in adipose tissue by a combination of RF and ultrasound energy, the method comprising:

(a) making a region of skin and underlying subcutaneous adipose tissue containing cytoplasm and intercellular fluids to protrude above the surrounding skin surface;

(b) directing to the adipose tissue made to protrude above the surrounding skin surface moderately focused ultrasound limited to a view angle of less than 120° to generate a pressure gradient between 0.5 GPa/m to 50 GPa/m in the adipose tissue; and

(c) applying RF energy to adipose tissue made to protrude above a surrounding skin surface, and

wherein the RF energy and the ultrasound energy combine in the cytoplasm and intercellular fluid of the adipose tissue thereby enhancing a selective cell membrane destruction without damage to other tissue.

16. An applicator for selective destruction of adipocytes in adipose tissue, the applicator comprising:

(a) a manipulator, the manipulator makes a region of skin and underlying subcutaneous adipose tissue containing cytoplasm and intercellular fluids to protrude above a surrounding skin surface;

(b) at least one source of moderately focused ultrasound energy limited to a view angle of less than 120° radiating ultrasound energy into the region of the skin and underlying subcutaneous adipose tissue made to protrude above the surrounding skin surface and heat said region of the skin to generate a pressure gradient between 0.5 GPa/m to 50 GPa/m in the adipose tissue;

(c) a pair of RF electrodes for application of RF energy to the region of the skin made to protrude above the surrounding skin surface and further heat said region of the skin to the protrusion, and

wherein the ultrasound energy and the RF energy combine in the cytoplasm and intercellular fluid of the adipose tissue made to protrude above the surrounding skin surface thereby enhancing a selective cell membrane destruction without damage to other tissue.

17. A method for selective destruction of adipocytes, the method comprising:

(a) applying at least one source of moderately focused ultrasound energy limited to a view of angle of less than 120° to a skin surface to generate a pressure gradient between 0.5 GP/m and 50 GP/m in adipose tissue;

(b) enhancing the pressure gradient at an expense of pressure amplitude at the focus volume by limiting the focusing of the ultrasound energy, such that selective effects on adipocytes will be obtained with reduced cavitation;

(c) generating relative movement between lipids and other constituents of adipocytes with sufficient intensity to rupture cell membranes of the adipocytes; and

(d) reducing unwanted cavitation effects while not reducing cell rupturing by moderately focusing the ultrasound energy and controlling the negative pressure magnitude of the ultrasound such that the pressure level does not cause cavitation in the adipocytes constituents.

18. The method according to claim 17 , further comprising detecting a generation of the cavitation in the adipose tissue by a sensor comprising a receiver tuned to half of an ultrasound transmitting frequency and varying ultrasound properties by a control unit to minimize the unwanted effects.

19. The method according to claim 17 , wherein the constituents of adipocytes comprise one or more of a lipid vacuole, cytoplasm fluid and intercellular fluids having different mass densities.

20. The method according to claim 17 , wherein said angle is limited to maximize ratio of pressure gradient to pressure at the focus volume.

21. The method according to claim 20 , wherein the moderately focused ultrasound energy is limited to a view angle of less than 90°, said angle is limited to maximize ratio of pressure gradient to pressure at the focus volume.

22. The method according to claim 17 , wherein to avoid penetration of the ultrasound energy to internal tissues and organs below an adipose tissue layer, the moderately focused ultrasound energy is radiated into a protrusion formed of the skin surface including the adipose tissue in a direction creating an angle of 90 degrees with a normal to the non-protruding skin surface.

23. The method according to claim 22 , wherein the protrusion is formed by one of vacuum means or mechanical manipulation of the adipose tissue.

24. The method according to claim 22 , wherein the ultrasound energy radiated by the source is transmitted through the protruding tissue region.

25. The method according to claim 17 , wherein the moderately focused ultrasound energy has a frequency lower than 1 MHz.

26. The method according to claim 17 , wherein differences between mass density of the constituents of the adipocytes assist in generating the relative movement between the constituents.

27. The method according to claim 17 , further comprising detecting a generation of the cavitation in the adipose tissue by a sensor comprising a receiver tuned to half of an ultrasound transmitting frequency and varying ultrasound properties by a control unit to minimize the unwanted effects.

28. The method according to claim 17 , wherein the moderately focused ultrasound energy generates the pressure gradient, more preferred between 2 GPa/m to 15 GPa/m.

Assignments (6)
NOTICE OF SUCCESSION OF AGENCY AT REEL/FRAME 059593/0269 Recorded May 29, 2026
From: BARCLAYS BANK PLC, AS PRIOR COLLATERAL AGENT
To: HSBC BANK USA, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 075648/0952 →
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Apr 4, 2022
From: CANDELA CORPORATION; SYNERON MEDICAL LTD.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059593/0269 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNORS' EXECUTION DATES PREVIOUSLY RECORDED ON REEL 017866, FRAME 0480. ASSIGNOR HEREBY CONFIRMS THE ASSIGNMENT OF THE ENTIRE INTEREST. Recorded Jul 31, 2006
From: ROSENBERG, AVNER; ECKHOUSE, SHIMON; KREINDEL, MICHEL
To: SYNERON MEDICAL LTD.
Reel/Frame 018139/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2006
From: ROSENBERG, AVNER; ECKHOUSE, SHIMON; KREINDEL, MICHAEL
To: SYNERON MEDICAL LTD.
Reel/Frame 017866/0480 →